Diamond‐Lipid Hybrids Enhance Chemotherapeutic Tolerance and Mediate Tumor Regression
- 15 April 2013
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 25 (26) , 3532-3541
Abstract
Self‐assembled nanodiamond‐lipid hybrid particles (NDLPs) harness the potent interaction between the nanodiamond (ND)‐surface and small molecules, while providing a mechanism for cell‐targeted imaging and therapy of triple negative breast cancers. Epidermal growth factor receptor‐targeted NDLPs are highly biocompatible particles that provide cell‐specific imaging, promote tumor retention of ND‐complexes, prevent epirubicin toxicities and mediate regression of triple negative breast cancers.Keywords
This publication has 49 references indexed in Scilit:
- Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInternational Journal of Nanomedicine, 2011
- The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNature Materials, 2011
- In Vivo Imaging and Toxicity Assessments of Fluorescent Nanodiamonds in Caenorhabditis elegansNano Letters, 2010
- Biology of Colorectal CancerThe Cancer Journal, 2010
- Gd(III)-Nanodiamond Conjugates for MRI Contrast EnhancementNano Letters, 2009
- Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular ArchitectureAccounts of Chemical Research, 2009
- Renal clearance of quantum dotsNature Biotechnology, 2007
- An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens: Table 1Journal of Clinical Pathology, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001